Back to Trades
Sell4
Viking Therapeutics, Inc.
VKTX
Total Value
$1.4M
Net $1.4M sold
Sales
$1.4M
1 transaction
Company Information
- Company Name
- Viking Therapeutics, Inc.
- Ticker Symbol
- VKTX
- CIK
- 0001607678
Insider Information
- Name
- Lian Brian
- Role
- Insider
- Location
- SAN DIEGO, CA
Filing Details
- Filing Date
- Oct 28, 2025
- Transaction Date
- Oct 27, 2025
- Accession Number
- 0001193125-25-254299
- Form Type
- 4
- Net Trading Amount
- -$1.4M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Oct 27, 2025 | Common Stock, par value $0.00001 per share | 70,084 | — | Grant/Award | — |
| Oct 28, 2025 | Common Stock, par value $0.00001 per share | 38,989 | $35.01 | Sale | $1.4M |
Footnotes
- (F1)The reported securities were subject to a performance restricted stock unit award that was granted on January 3, 2025, 33.33% of which vested on October 27, 2025 upon the achievement of a non-financial performance goal and 15% of which vested also on October 27, 2025 upon the partial achievement of a non-financial performance goal.
- (F2)These shares were automatically sold on a non-discretionary basis solely to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to the performance restricted stock unit award described in Footnote 1.
- (F3)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.66 to $35.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the this footnote.